HBV Treatment
World Health Organization Issues First Hepatitis B Prevention and Treatment Guidelines
- Details
- Category: HBV Treatment
- Published on Tuesday, 17 March 2015 00:00
- Written by WHO
The World Health Organization (WHO) released its first-ever guidelines for the prevention, care, and treatment of hepatitis B virus (HBV) infection, a major cause of illness and death worldwide. For treatment, WHO recommends the antivirals tenofovir (Viread) or entecavir (Baraclude), and says that people with liver cirrhosis need treatment most urgently.
11. Hepatitis B: Interferon Boosts Cure Rate, Tenofovir Works Long-Term
- Details
- Category: HBV Treatment
- Published on Monday, 12 January 2015 00:00
- Written by HIVandHepatitis.com
Compared with hepatitis C and HIV, the hepatitis B treatment field moves slowly, but a number of studies presented in 2014 advanced knowledge about how best to treat chronic hepatitis B virus (HBV) with existing therapies and offered some promising agents in the pipeline.
AASLD 2014: Entecavir and Tenofovir Work Well for People with Resistant Hepatitis B Virus
- Details
- Category: HBV Treatment
- Published on Tuesday, 16 December 2014 00:00
- Written by Liz Highleyman
A combination of entecavir plus tenofovir effectively suppressed hepatitis B virus (HBV) in people with resistance to other antivirals, according to results from the ENTEBE study presented at the American Association for the Study of Liver Diseases (AASLD) Liver Meeting last month in Boston. Another study, however, showed that for some resistant patients, tenofovir worked equally well on its own.
AASLD 2014: Experimental siRNA Therapy Lowers HBsAg Levels in Hepatitis B Patients
- Details
- Category: HBV Treatment
- Published on Tuesday, 23 December 2014 00:00
- Written by Liz Highleyman
ARC-520, a novel therapy using short interfering RNA, appeared safe and was associated with a reduction in hepatitis B surface antigen levels in chronic hepatitis B patients taking entecavir, according to Phase 2a study results reported at the American Association for the Study of Liver Diseases (AASLD) Liver Meeting last month in Boston.
Coverage of the 2014 AASLD Liver Meeting
- Details
- Category: HBV Treatment
- Published on Tuesday, 02 December 2014 00:00
- Written by HIVandHepatitis.com
HIVandHepatitis.com coverage of the 65th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD 2014) in Boston, November 7-11, 2014.
Conference highlights include new interferon-free therapy for hepatitis C -- including options for people with cirrhosis, and liver transplant recipients -- treatment for hepatitis B, and prevention and management of advanced liver disease.
12/2/14
Web Design and Development by